Teva recalls cardiac jab after wrong Canadian label
This article was originally published in Scrip
Executive Summary
Teva Novopharm has been forced to recall a batch of its Dobutamine Hydrochloride Injection 250mg/20mL in Canada, following a labelling error which instructed dosing in units of measure 1,000 times higher than recommended.